Victoria A. Klyagina
Victoria A. Klyagina has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Evgeniy V. Merkulov
E.I. Chazov National Medical Research Center Of Cardiology
4 shared publications - Goar Kimovna Arutyunyan
Chazov National Medical Research Center of Cardiology
4 shared publications - Andrey S. Tereshchenko
Chazov National Medical Research Center of Cardiology
3 shared publications - Dmitry V. Pevzner
Chazov National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation; M.F. Vladimirsky Moscow Regional Research and Clinical Institute
3 shared publications - Khava U. Ibragimova
Chazov National Medical Research Center of Cardiology
3 shared publications - Tatiana S. Sukhinina
Chazov National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
3 shared publications
Latest Publications
- Open Access
- 4 September 2026
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 15 (4) , 22-32
STAGED MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION AND MULTIVESSEL CORONARY ARTERY DISEASE BASED ON CORONARY PHYSIOLOGY PARAMETERS IN NON-INFARCT-RELATED ARTERIES: ANALYSIS OF OUTCOMES ACCORDING TO MID-TERM FOLLOW-UP
Highlights The study demonstrates that in patients with uncomplicated STEMI and intermediate stenoses of non-infarct-related arteries, performing staged complete revascularization only with a hemodynamically significant fractional flow reserve (FFR) value ≤ 0.80 at 30–45 days after primary intervention is associated with no cases of cardiovascular death and recurrent myocardial infarction over a median follow-up of 21 months. The uniqueness of the approach lies in the selection of hemodynamically significant stenoses, which avoided excessive stenting in 40% of patients without worsening prognosis. Thus, the work makes an important contribution to the rationale for FFR-guided staged complete revascularization in STEMI patients with multivessel coronary artery disease. Aim. To evaluate the incidence of major adverse cardiovascular events in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease after staged complete revascularization of non-infarct-related arteries (non-IRAs) guided by fractional flow reserve (FFR). Methods. This single-center prospective study included 52 patients with STEMI and intermediate non-IRA stenoses (50–85%). All patients underwent primary percutaneous coronary intervention of the infarct-related artery. At 30–45 days, FFR assessment in non-IRAs was performed; revascularization was performed when FFR ≤ 0.80. Median follow-up was 21 months. The primary endpoint was cardiovascular death and recurrent myocardial infarction. Results. Hemodynamically significant stenoses were identified in 31 patients (59.6%), who underwent stenting; 21 patients (40.4%) received only medical therapy. During the follow-up period, no cases of cardiovascular death or recurrent myocardial infarction were recorded (0%; 95% CI 0.0–5.6%). Repeat revascularization was performed in 4 patients (7.7%), and 2 cases of non-cardiovascular death (3.8%) were recorded. No cases of contrast-induced nephropathy, clinically significant bleeding, or stroke were observed. Conclusion. In patients with uncomplicated STEMI and intermediate non-IRA stenoses, an FFR-guided staged complete revascularization strategy performed at 30–45 days after primary intervention was associated with a low incidence of cardiovascular events; no cases of cardiovascular death or recurrent myocardial infarction were recorded in this cohort. This approach avoids excessive stenting but requires confirmation in larger studies.
- 4 September 2026
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 15 (4) , 22-32
Open AccessSTAGED MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION AND MULTIVESSEL CORONARY ARTERY DISEASE BASED ON CORONARY PHYSIOLOGY PARAMETERS IN NON-INFARCT-RELATED ARTERIES: ANALYSIS OF OUTCOMES ACCORDING TO MID-TERM FOLLOW-UP
Highlights The study demonstrates that in patients with uncomplicated STEMI and intermediate stenoses of non-infarct-related arteries, performing staged complete revascularization only with a hemodynamically significant fractional flow reserve (FFR) value ≤ 0.80 at 30–45 days after primary intervention is associated with no cases of cardiovascular death and recurrent myocardial infarction over a median follow-up of 21 months. The uniqueness of the approach lies in the selection of hemodynamically significant stenoses, which avoided excessive stenting in 40% of patients without worsening prognosis. Thus, the work makes an important contribution to the rationale for FFR-guided staged complete revascularization in STEMI patients with multivessel coronary artery disease. Aim. To evaluate the incidence of major adverse cardiovascular events in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease after staged complete revascularization of non-infarct-related arteries (non-IRAs) guided by fractional flow reserve (FFR). Methods. This single-center prospective study included 52 patients with STEMI and intermediate non-IRA stenoses (50–85%). All patients underwent primary percutaneous coronary intervention of the infarct-related artery. At 30–45 days, FFR assessment in non-IRAs was performed; revascularization was performed when FFR ≤ 0.80. Median follow-up was 21 months. The primary endpoint was cardiovascular death and recurrent myocardial infarction. Results. Hemodynamically significant stenoses were identified in 31 patients (59.6%), who underwent stenting; 21 patients (40.4%) received only medical therapy. During the follow-up period, no cases of cardiovascular death or recurrent myocardial infarction were recorded (0%; 95% CI 0.0–5.6%). Repeat revascularization was performed in 4 patients (7.7%), and 2 cases of non-cardiovascular death (3.8%) were recorded. No cases of contrast-induced nephropathy, clinically significant bleeding, or stroke were observed. Conclusion. In patients with uncomplicated STEMI and intermediate non-IRA stenoses, an FFR-guided staged complete revascularization strategy performed at 30–45 days after primary intervention was associated with a low incidence of cardiovascular events; no cases of cardiovascular death or recurrent myocardial infarction were recorded in this cohort. This approach avoids excessive stenting but requires confirmation in larger studies.
- 16 April 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (3)
Coronary physiology indicators for assessing the stenosis functional significance in non-infarct-related arteries in patients with ST-segment elevation myocardial infarction
Aim . To study the informative value of invasive coronary physiology indices (fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR)) and to evaluate the safety of papaverine as a hyperemic agent to determine the hemodynamic significance of stenoses in non-infarction-related arteries (non-IRA) in patients with ST-segment elevation myocardial infarction (STEMI) during the index procedure after primary percutaneous coronary intervention (PPCI). Material and methods . This single-center prospective study included 32 patients over 18 years of age with STEMI and 50-85% stenosis in 38 non-IRA. After PPCI of the infarction-related artery, iFR, contrast-enhanced FFR, and (if there were no contraindications) FFR with papaverine were measured. Rehospitalization was performed 30-45 days later with follow-up coronary angiography and reassessment of physiological parameters. Statistical analysis included Spearman’s rank order coefficient (SRCC), intraclass correlation (ICC), Cohen’s kappa coefficient, Bland-Altman analysis, and McNemar’s test (α=0,05). Results . Analysis of 38 non-IRAs (36 FFR tests with papaverine) demonstrated high reproducibility as follows: iFR — ρ=0,94 (pConclusion . FFR with papaverine and iFR can be safely and informatively used to assess the hemodynamic significance of non-IRA stenoses in hemodynamically stable patients during the first 24 hours after STEMI. The high stability of these parameters during repeated measurements confirms their suitability for dynamic monitoring. Borderline values require careful interpretation and possible use of additional ischemia verification methods.
- 16 April 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (3)
Coronary physiology indicators for assessing the stenosis functional significance in non-infarct-related arteries in patients with ST-segment elevation myocardial infarction
Aim . To study the informative value of invasive coronary physiology indices (fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR)) and to evaluate the safety of papaverine as a hyperemic agent to determine the hemodynamic significance of stenoses in non-infarction-related arteries (non-IRA) in patients with ST-segment elevation myocardial infarction (STEMI) during the index procedure after primary percutaneous coronary intervention (PPCI). Material and methods . This single-center prospective study included 32 patients over 18 years of age with STEMI and 50-85% stenosis in 38 non-IRA. After PPCI of the infarction-related artery, iFR, contrast-enhanced FFR, and (if there were no contraindications) FFR with papaverine were measured. Rehospitalization was performed 30-45 days later with follow-up coronary angiography and reassessment of physiological parameters. Statistical analysis included Spearman’s rank order coefficient (SRCC), intraclass correlation (ICC), Cohen’s kappa coefficient, Bland-Altman analysis, and McNemar’s test (α=0,05). Results . Analysis of 38 non-IRAs (36 FFR tests with papaverine) demonstrated high reproducibility as follows: iFR — ρ=0,94 (pConclusion . FFR with papaverine and iFR can be safely and informatively used to assess the hemodynamic significance of non-IRA stenoses in hemodynamically stable patients during the first 24 hours after STEMI. The high stability of these parameters during repeated measurements confirms their suitability for dynamic monitoring. Borderline values require careful interpretation and possible use of additional ischemia verification methods.
- 30 December 2025
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 20 (4) , 145-154
Sensitivity and specificity of various physiological indices of coronary blood flow for functional assessment of coronary artery stenosis
Objective. To analyze sensitivity and specificity of non-hyperemic indices (Pd/Pa, diastolic blood flow reserve), contrast-induced hyperemia index (cFFR) compared with fractional flow reserve (FFR) in patients with coronary artery disease (CAD) and various lesions of coronary arteries. Material and methods. The study included 61 patients with chronic CAD, coronary artery stenosis >50% and diameter >2.5 mm as assessed by angiography. A total of 108 lesions were enrolled. Of these, FFR was assessed in 79, non-hyperemic indices were measured in 74, and contrast-induced hyperemia index was assessed in 37 cases. All indices were analyzed in comparison with FFR. The criterion for hemodynamic significance of stenosis was FFR≤0.80. Analysis of correlation, sensitivity and specificity of these parameters was performed. False-negative and false-positive results were assessed at cut-off DFR≤0.89. Results. cFFR significantly positively correlates with FFR (p<0.0001, r=0.803). Non-hyperemic indices positively moderately correlate with FFR (for Pd/Pa p<0.0001, r=0.61; for DFR p<0.0001, r=0.587). In cFFR with cut-off value ≤ 0.83, sensitivity was 84.6%, specificity — 100%. In Pd/Pa with cut-off value ≤0.91, sensitivity was 73.5%, specificity — 80%. For DFR≤0.89, the sensitivity was 83.7%; specificity 68%. DFR can depend on measurements in different coronary arteries. There were significant differences towards underestimation of non-hyperemic indices in LAD and overestimation in RCA and LCx (p<0.001). Conclusion. Contrast-induced hyperemia index (cFFR) may be an alternative to FFR with papaverine. Although predictive value of non-hyperemic Pd/Pa and DFR indices was acceptable, they depended on anatomical localization of lesion. This can require further research.
- 30 December 2025
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 20 (4) , 145-154
Sensitivity and specificity of various physiological indices of coronary blood flow for functional assessment of coronary artery stenosis
Objective. To analyze sensitivity and specificity of non-hyperemic indices (Pd/Pa, diastolic blood flow reserve), contrast-induced hyperemia index (cFFR) compared with fractional flow reserve (FFR) in patients with coronary artery disease (CAD) and various lesions of coronary arteries. Material and methods. The study included 61 patients with chronic CAD, coronary artery stenosis >50% and diameter >2.5 mm as assessed by angiography. A total of 108 lesions were enrolled. Of these, FFR was assessed in 79, non-hyperemic indices were measured in 74, and contrast-induced hyperemia index was assessed in 37 cases. All indices were analyzed in comparison with FFR. The criterion for hemodynamic significance of stenosis was FFR≤0.80. Analysis of correlation, sensitivity and specificity of these parameters was performed. False-negative and false-positive results were assessed at cut-off DFR≤0.89. Results. cFFR significantly positively correlates with FFR (p<0.0001, r=0.803). Non-hyperemic indices positively moderately correlate with FFR (for Pd/Pa p<0.0001, r=0.61; for DFR p<0.0001, r=0.587). In cFFR with cut-off value ≤ 0.83, sensitivity was 84.6%, specificity — 100%. In Pd/Pa with cut-off value ≤0.91, sensitivity was 73.5%, specificity — 80%. For DFR≤0.89, the sensitivity was 83.7%; specificity 68%. DFR can depend on measurements in different coronary arteries. There were significant differences towards underestimation of non-hyperemic indices in LAD and overestimation in RCA and LCx (p<0.001). Conclusion. Contrast-induced hyperemia index (cFFR) may be an alternative to FFR with papaverine. Although predictive value of non-hyperemic Pd/Pa and DFR indices was acceptable, they depended on anatomical localization of lesion. This can require further research.
- 18 September 2025
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 20 (3)
Ultrasound catheter thrombolysis for the treatment of pulmonary embolism: the first experience in the Russian Federation
Treatment of pulmonary embolism (PE) is still an urgent problem worldwide due to complications of systemic thrombolytic therapy. This review examines ultrasound catheter thrombolysis using the EKOS system, indications, patient selection and current state of the issue. The device itself, appropriate manipulations and several clinical cases in the Russian Federation are described in detail. The authors described implantation technique and ultrasound thrombolysis.
- 18 September 2025
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 20 (3)
Ultrasound catheter thrombolysis for the treatment of pulmonary embolism: the first experience in the Russian Federation
Treatment of pulmonary embolism (PE) is still an urgent problem worldwide due to complications of systemic thrombolytic therapy. This review examines ultrasound catheter thrombolysis using the EKOS system, indications, patient selection and current state of the issue. The device itself, appropriate manipulations and several clinical cases in the Russian Federation are described in detail. The authors described implantation technique and ultrasound thrombolysis.